NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00049998,"Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer",https://clinicaltrials.gov/study/NCT00049998,,COMPLETED,"The purpose of this study is to collect information on how effective and how well tolerated an oral investigational drug is compared to a standard intravenous drug in patients with pretreated, advanced non-small lung cancer (NSCLC).",NO,Non-Small-Cell Lung Cancer,DRUG: topotecan,One-year survival rate,"overall survival, time to progression, response rate, response duration, time to response, improvement in quality of life and patient well-being, and qualitative and quantitative toxicities.",,GlaxoSmithKline,,ALL,"ADULT, OLDER_ADULT",PHASE3,760,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,104864-A/387,2001-10,2004-04,,2002-11-20,,2013-03-04,"GSK Investigational Site, Adelaide, South Australia, 5000, Australia|GSK Investigational Site, Bedford Park, South Australia, 5042, Australia|GSK Investigational Site, Melbourne, Victoria, 3004, Australia|GSK Investigational Site, Ringwood East, Victoria, 3128, Australia|GSK Investigational Site, Innsbruck, A-6020, Austria|GSK Investigational Site, St Poelten, A-3100, Austria|GSK Investigational Site, Vienna, A-1220, Austria|GSK Investigational Site, Braasschaat, 2930, Belgium|GSK Investigational Site, Bruxelles, 1200, Belgium|GSK Investigational Site, Edegem, 2650, Belgium|GSK Investigational Site, Liege, 4000, Belgium|GSK Investigational Site, Sydney, Nova Scotia, B1P 1P3, Canada|GSK Investigational Site, Oshawa, Ontario, L1G 2B9, Canada|GSK Investigational Site, Thunder Bay, Ontario, P7B 6V4, Canada|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Toronto, Ontario, M6S 1B5, Canada|GSK Investigational Site, Greenfield Park, Quebec, J4V 2H1, Canada|GSK Investigational Site, Montreal, Quebec, H3A 1A1, Canada|GSK Investigational Site, Sainte-Foy, Quebec, G1V 4G5, Canada|GSK Investigational Site, Xian, Shaanxi, 710061, China|GSK Investigational Site, Beijing, 100036, China|GSK Investigational Site, Shanghai, 200433, China|GSK Investigational Site, Shanghai, China|GSK Investigational Site, Tianjin, China|GSK Investigational Site, Wangfujing, Beijing, 100730, China|GSK Investigational Site, Ceske Budejovice, 370 87, Czech Republic|GSK Investigational Site, Kladno, 140 59, Czech Republic|GSK Investigational Site, Praha 4, 14059, Czech Republic|GSK Investigational Site, Herlev, Denmark|GSK Investigational Site, Odense C, DK-5000, Denmark|GSK Investigational Site, Helsinki, 00029, Finland|GSK Investigational Site, Turku, 20520, Finland|GSK Investigational Site, Caen Cedex 5, 14076, France|GSK Investigational Site, Dijon Cedex, 21079, France|GSK Investigational Site, Strasbourg Cedex, 67098, France|GSK Investigational Site, Toulon Naval, 83800, France|GSK Investigational Site, Vesoul Cedex, 70014, France|GSK Investigational Site, Gauting, Bayern, 82131, Germany|GSK Investigational Site, Muenchen, Bayern, 80336, Germany|GSK Investigational Site, Regensburg, Bayern, 93049, Germany|GSK Investigational Site, Treuenbrietzen, Brandenburg, 14929, Germany|GSK Investigational Site, Leipzig, Sachsen, 04207, Germany|GSK Investigational Site, Bad Berka, Thueringen, 99437, Germany|GSK Investigational Site, Berlin, 14109, Germany|GSK Investigational Site, Hamburg, 21075, Germany|GSK Investigational Site, Athens, 11526, Greece|GSK Investigational Site, Heraklion, Crete, 71110, Greece|GSK Investigational Site, Papagos, Athens, 15669, Greece|GSK Investigational Site, Rio, Patras, 265 00, Greece|GSK Investigational Site, Thessaloniki, 54007, Greece|GSK Investigational Site, Budapest, 1529, Hungary|GSK Investigational Site, Csorna, 9300, Hungary|GSK Investigational Site, Miskolc, 3529, Hungary|GSK Investigational Site, Ashkelon, 78306, Israel|GSK Investigational Site, Beer-Sheva, 84101, Israel|GSK Investigational Site, Ramat Gan, 52621, Israel|GSK Investigational Site, Tel Aviv, 64239, Israel|GSK Investigational Site, Roma, Lazio, 00149, Italy|GSK Investigational Site, Torino, Piemonte, 10126, Italy|GSK Investigational Site, Sassari, Sardegna, 07100, Italy|GSK Investigational Site, Perugia, Umbria, 06122, Italy|GSK Investigational Site, Verona, Veneto, 37135, Italy|GSK Investigational Site, Riga, LV 1002, Latvia|GSK Investigational Site, Riga, LV 1079, Latvia|GSK Investigational Site, Kaunas, LT-50009, Lithuania|GSK Investigational Site, Vilnius, LT-08660, Lithuania|GSK Investigational Site, 's-HERTOGENBOSCH, 5211 NL, Netherlands|GSK Investigational Site, Delft, 2625 AD, Netherlands|GSK Investigational Site, Groningen, 9721 SW, Netherlands|GSK Investigational Site, Heerlen, 6419 PC, Netherlands|GSK Investigational Site, Leeuwarden, 8934 AD, Netherlands|GSK Investigational Site, Newtown, Wellington, 6002, New Zealand|GSK Investigational Site, Quezon City, 1100, Philippines|GSK Investigational Site, Poznan, 60-569, Poland|GSK Investigational Site, Warszawa, 02-781, Poland|GSK Investigational Site, Lisboa, 1769-166, Portugal|GSK Investigational Site, Porto, 4200-319, Portugal|GSK Investigational Site, Moscow, 115 478, Russian Federation|GSK Investigational Site, Moscow, 117 837, Russian Federation|GSK Investigational Site, Moscow, 129 128, Russian Federation|GSK Investigational Site, N. Novgorod, 603 000, Russian Federation|GSK Investigational Site, Samara, 443066, Russian Federation|GSK Investigational Site, St. Petersburg, 198255, Russian Federation|GSK Investigational Site, Singapore, 119074, Singapore|GSK Investigational Site, Pretoria, Gauteng, South Africa|GSK Investigational Site, Cape Town, Western Province, South Africa|GSK Investigational Site, Port Elizabeth, 6001, South Africa|GSK Investigational Site, Barakaldo (Vizcaya), 48903, Spain|GSK Investigational Site, Jaen, 23007, Spain|GSK Investigational Site, La Laguna (Santa Cruz de Tenerife), 38320, Spain|GSK Investigational Site, Lerida, 25198, Spain|GSK Investigational Site, Madrid, 28007, Spain|GSK Investigational Site, Madrid, 28040, Spain|GSK Investigational Site, Madrid, 28047, Spain|GSK Investigational Site, Malaga, 29020, Spain|GSK Investigational Site, Palma de Mallorca, 07014, Spain|GSK Investigational Site, Pontevedra, 36002, Spain|GSK Investigational Site, Valencia, 46009, Spain|GSK Investigational Site, Zurich, CH-8091, Switzerland|GSK Investigational Site, Taipei, 100, Taiwan|GSK Investigational Site, Tau-Yuan County, 333, Taiwan|GSK Investigational Site, Bangkok, 10400, Thailand|GSK Investigational Site, Chiang Mai, 50200, Thailand|GSK Investigational Site, Istanbul, 34280, Turkey|GSK Investigational Site, Izmir, 3510, Turkey|GSK Investigational Site, Kharkov, Ukraine|GSK Investigational Site, Lugansk, Ukraine|GSK Investigational Site, Lvov, 79031, Ukraine|GSK Investigational Site, Dundee, Forfarshire, DD1 9SY, United Kingdom|GSK Investigational Site, Glasgow, Lanarkshire, G4 0SF, United Kingdom|GSK Investigational Site, Leicester, Leicestershire, LE1 5WW, United Kingdom|GSK Investigational Site, Nottingham, Nottinghamshire, United Kingdom|GSK Investigational Site, Guildford, Surrey, GU2 7XX, United Kingdom|GSK Investigational Site, London, SE1 9RT, United Kingdom",
